VivoSeq
Other

Upper Gastrointestinal Bleeding

0

Pipeline Programs↗

3

Active Trials↗

2

Companies Involved↗

Upper Gastrointestinal Bleeding is an early-stage landscape with 0 programs across 2 companies. The most active players are UCB, AstraZeneca.

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

86/100

Attrition Rate

6/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

UCB logo

UCB

0 programs

PreclinicalAstraZeneca logo

AstraZeneca

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

16

clinical trials

Unknown status6 · 38%
Completed6 · 38%
Recruiting2 · 13%
Not yet recruiting1 · 6%
Withdrawn1 · 6%

Clinical Trials

Trial Activity

16 trials

Randomized Active-Controlled Trial Evaluating Fexuprazan (Fexuclue Tab) for Prevention Upper Gastrointestinal Bleeding in High Bleeding Risk Patients Receiving Dual Antiplatelet Therapy After Coronary Intervention
Recruiting·SSUK MIN SEO·N/A·NCT07479056·400 enrolled
Tranxemic Acid and Vitamin K Injection to Control Upper Gastrointestinal Bleeding in Cirrhotic Patients
Recruiting·TTanta University·Phase 4·NCT06881628·194 enrolled
Effect of Ondansetron on Patient Tolerance, Efficacy and Endoscopist Workload in Unsedated Endoscopy for Upper Gastrointestinal Bleeding
Not yet recruiting·PPeking Union Medical College Hospital·Phase 4·NCT07336680·80 enrolled
Study to Assess the Efficacy and Safety of Somatostatin in the Treatment of Acute Severe Upper Gastrointestinal Bleeding
Completed·UCB logoUCB·Phase 2·NCT00152399·370 enrolled
Efficacy and Safety Study of Esomeprazole vs Omeprazole to Treat Acute Non-Variceal Upper Gastrointestinal Bleeding
Completed·AstraZeneca logoAstraZeneca·Phase 3·NCT00402259·440 enrolled
To Compare a Hemostatic Powder TC-325 and Standard Treatment in the Control of Acute Upper Gastrointestinal Bleeding From Nonvariceal Causes
Completed·—·Phase 3·NCT02534571·224 enrolled
Administration of High-Dose Intravenous Proton Pump Inhibitor for Upper Gastrointestinal Bleeding Prior to Endoscopy
Completed·—·Phase 4·NCT00164866·638 enrolled
Usefulness of Metoclopramide to Improve Endoscopic Visualization in Upper Gastrointestinal Bleeding
Completed·UUniversidad Autonoma de Nuevo Leon·Phase 3·NCT06297954·50 enrolled
Effects of Different Omeprazole Dosing on Gastric pH in Non-variceal Upper Gastrointestinal Bleeding
Completed·MMedical University of Bialystok·Phase 4·NCT03980496·50 enrolled
Effect of Tranexamic Acid in Upper Gastrointestinal Bleeding
Withdrawn·UUniversity of Oklahoma·N/A·NCT01005147
Efficacity and Safety of Tranexamic Acid in Cirrhotic Patients Presenting With Acute Upper Gastrointestinal Bleeding
Unknown status·AAssistance Publique - Hôpitaux de Paris·Phase 4·NCT03023189·500 enrolled
Efficacy of Tranexamic Acid in Upper Gastrointestinal Bleeding
Unknown status·PPost Graduate Institute of Medical Education and Research, Chandigarh·Phase 3·NCT04788121·160 enrolled
Tranexamic Acid for Upper Gastrointestinal Bleeding
Unknown status·SSeoul National University Hospital·Phase 3·NCT01713101·414 enrolled
The Use of Hexacapron in Upper Gastrointestinal Bleeding
Unknown status·SShaare Zedek Medical Center·N/A·NCT02071316·300 enrolled
Erythromycin Versus Gastric Lavage to Improve Quality of Endoscopy in Patients With Upper Gastrointestinal Bleeding
Unknown status·HHospital Universitari de Bellvitge·Phase 3·NCT01716572·122 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)